CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Contributers

Recommended Insights

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

Top Biotech Developments to Watch for

Jeremy Williams, Life Science Review

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

In Personalized Medicine Logistics,...

Scott Ohanesian, Senior VP Commercial Operations,...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

Top Biotech Developments to Watch for

Jeremy Williams, Life Science Review

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

In Personalized Medicine Logistics,...

Scott Ohanesian, Senior VP Commercial Operations,...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

The Need for Innovation in Drug Discovery

Darryl McConnell, SVP, Research Site Head Austria, Boehringer Ingelheim
Tweet

Drug discovery and development is a prolonged, complex and costly process, constantly accompanied by the high degree of uncertainty whether a drug will succeed. The journey of drug discovery begins with the search for insights into diseases. From this, flow ideas about how a disease could be stopped or even reversed. It then becomes an iterative process of searching for the right drug molecule and learning more about the disease itself. Drug discovery takes 1 in 100 projects to be successful and around 15 years from start to finish. Clearly, new technologies and new approaches are needed to reach the “high hanging fruits” such as the so-called “undruggable targets” and to accelerate the path to drug approval.


The Need to Innovate


Drug discovery is like exploration; every day we have to decide which way to go to come closer to discovering a breakthrough medicine for patients. The challenge is equally, the ability to choose the right direction and to realise quickly when a wrong turn has been taken. Researchers need the courage to explore the unexplored and the appetite to innovate but also the ability to continually question the choices they have made. The “undruggable” cancer targets are an example of unexplored space in drug discovery which has great potential for patients. RAS, P53, MYC and beta-Catenin are proteins found in the human body, and when mutated, cause more than half of all cancers. Drugging these targets is an immensely difficult undertaking but the value to patients if we succeed, will be equally large.


Starting each project with an understanding of what the patient needs is key to success and we should encourage young entrepreneurs and researchers to think this way. Discovering a path to deliver a breakthrough therapy to patients is arguably one of the most challenging of human endeavours and this journey starts and ends with the patient.


Technology in Drug Discovery and Development


A lot has changed within the industry in the past ten years. New science and technologies are constantly emerging, some of which change the game. The rate of adoption of these game-changing technologies is becoming so fast that you need to be an early adopter to gather the expertise to be able to apply the technology and be competitive. With pharmaceutical drug discovery companies evolving to data-centric companies, artificial intelligence (AI) based tools are being applied across drug discovery and development. AI promises to be the next game changer.


Capability to Learn


One of the key challenges of drug discovery that is rarely talked about is the ability to learn. The organisations that continuously learn will be the best drug hunters and deliver the most value to patients. Learning doesn’t need to be limited to experimentation it can also be done at the drawing board. Many scientists seek confirmation from others regarding how good their ideas are. By asking others why their idea is bad, flaws can be identified before expensive experimentation is needed. Learning together in real-time is key to innovating.


Weekly Brief

loading
Towards a New World Order
> <
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue

Read Also

Challenges To Clinical System In China

Cheryl Chen, Director of Clinical Operations, BeiGene
Challenges To Clinical System In China

On Accelerating Bioanalytical Workflow Automation

Ming Li, Director, Bioanalytical and Biomarker Outsourcing Operations, Alexion Pharmaceuticals
On Accelerating Bioanalytical Workflow Automation

Artificial Intelligence and the Healthcare Industry

Kelly H. Zou, PhD, PStat®, FASA, Head of Global Medical Analytics and Real World Evidence, Viatris
Artificial Intelligence and the Healthcare Industry

Cell and Gene therapy - Navigating the next frontier in biomanufacturing

Narayana Rao, Vice President of Biopharma, Asia Pacific Middle-East Africa, Avantor
Cell and Gene therapy - Navigating the next frontier in biomanufacturing
Improvements in Insulin Delivery Over Time and Expectations for the Future

Improvements in Insulin Delivery Over Time and Expectations for the Future

Jesper Lekdorf, MD, Sr Medical Director, Head of Medical Affairs, Novo Nordisk Japan
Machine Learning in the Life Sciences

Machine Learning in the Life Sciences

Eric Staib, Vice President, Compliance & Quality Management, Signant Health

Harnessing Big Data to Accelerate Clinical Trial Recruitment

Leigh Householder, Executive Vice President, Omnichannel Strategy; Claire Riches, Senior Vice President, Global Solutions; and Brooke Belk, Vice President, Program Strategy, Syneos Health
Harnessing Big Data to Accelerate Clinical Trial Recruitment

How Will Digital Transformation Revolutionize The Pharma Sector In The Light Of The Covid-19 Pandemic?

Robert Peterson, Head Of Sales Health and Life Sciences Americas and Asia, BT - Health and Life Sciences
How Will Digital Transformation Revolutionize The Pharma Sector In The Light Of The Covid-19 Pandemic?
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/cxoinsight/the-need-for-innovation-in-drug-discovery-nwid-31.html